Related Experiment Video
Updated: May 27, 2026

Stable Knockdown of Genes Encoding Extracellular Matrix Proteins in the C2C12 Myoblast Cell Line Using Small-Hairpin (sh)RNA
Published on: February 12, 2020
shRNA-mediated gene knockdown in skeletal muscle.
Muriel Golzio1, Jean-Michel Escoffre, Justin Teissié
1CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse, Toulouse, France. muriel.golzio@ipbs.fr
In vivo electropulsation safely delivers shRNA plasmids for long-term gene silencing in muscles. This RNA interference approach effectively blocks protein expression for over two months without causing lasting tissue damage.
Area of Science:
- Molecular Biology
- Biotechnology
- Gene Therapy
Background:
- RNA interference (RNAi) offers therapeutic potential for gene silencing.
- Short hairpin RNA (shRNA) expression in situ enables sustained gene silencing.
- Physical methods like in vivo electropulsation provide a safe delivery route.
Purpose of the Study:
- To evaluate the efficacy and safety of in vivo electropulsation for shRNA delivery.
- To assess the duration and specificity of gene silencing induced by this method.
- To identify key parameters for successful long-term gene silencing.
Main Methods:
- Co-electrotansfer of plasmids encoding expression and silencing of a fluorescent protein into mouse muscles.
- In vivo electropulsation using plate electrodes with optimized electric pulsing parameters.
- Noninvasive fluorescence imaging assay to monitor protein expression and gene silencing.
Main Results:
- In vivo electropulsation successfully delivered shRNA plasmids into mouse muscles.
- Complete gene silencing was observed for over two months.
- No long-lived tissue damage was detected with optimized parameters and plasmid amounts.
- Plasmid characteristics (sequence, promoter, relative amounts) were identified as crucial for long-term silencing.
Conclusions:
- In vivo electropulsation is a safe and effective physical method for delivering shRNA for therapeutic gene silencing.
- This approach enables sustained, specific gene silencing in muscles for extended periods.
- Optimization of plasmid design and delivery parameters is essential for achieving long-lasting therapeutic effects.
More Related Videos
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
06:37Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo
Published on: September 18, 2019
Related Concept Videos
Experimental RNAi
In-vitro Mutagenesis